United States · FDA National Drug Code directory
SENSORCAINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-463_cc1f6507-eb3e-4398-a1d3-0c56a2099e6b
- Product NDC
- 63323-463
- Form
- INJECTION, SOLUTION
- Composition / generic term
- BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101119
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 5 mg/mL
- EPINEPHRINE BITARTRATE — .005 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, MULTI-DOSE in 1 TRAY (63323-463-57) / 50 mL in 1 VIAL, MULTI-DOSE (63323-463-01) · 63323-463-57
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →